Aleck Jones
CEO and Co-Founder, Kindling Bio
Kindling Bio is pioneering the first scalable immunotherapy for childhood cancer. Our Immune Flag gene therapy platform transforms neglected paediatric indications into a launchpad into major adult cancer market expansion.
Events Aleck Jones has spoken at
- Advanced Therapies UK 2027 9 March 2027 – 10 March 2027
- BioTrinity 2026 14 April 2026 – 15 April 2026